Smoking cessation in severe mental illness: combined long-term quit rates from the UK SCIMITAR trials programme

Br J Psychiatry. 2021 Feb;218(2):95-97. doi: 10.1192/bjp.2019.192.

Abstract

Smoking contributes to health inequalities for people with severe mental illness (SMI). Although smoking cessation interventions are effective in the short term, there are few long-term trial-based estimates of abstinence. The SCIMITAR trials programme includes the largest trial to date of a smoking cessation intervention for people with SMI, but this was underpowered to detect anticipated long-term quit rates. By pooling pilot and full-trial data we found that quit rates were maintained at 12 months (OR = 1.67, 95% CI 1.02-2.73, P = 0.04). Policymakers can now be confident that bespoke smoking cessation interventions produce successful short- and long-term quitting.

Keywords: Psychotic disorders; anthropology; mortality; pharmaceutical drug trial; statistical methodology.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Mental Disorders* / epidemiology
  • Mental Disorders* / therapy
  • Smoking
  • Smoking Cessation*
  • United Kingdom / epidemiology